42. LTBI: New Options for Short Course Treatment
Session: Pre-meeting Session: Update on Tuberculosis
Thursday, October 20, 2011: 8:00 AM
Room: 204AB
  • 1.Carol Dukes Hamilton_LTBI-New Options for Short Course Treatment REFERENCES.pdf (8.0 kB)
  • 1.Carol Dukes Hamilton_LTBI-New Options for Short Course Treatment PRESENTATION.pdf (521.6 kB)
  • Data will be presented on existing and newer treatment options for latent TB infection, including shorter course single and double-agent treatment strategies.  Benefits and risks for various options will be presented, and current CDC recommendations will be reviewed.

    Carol Hamilton, MD, MHS, Health & Development Sciences, Family Health International (FHI), Durham, NC

    Carol Dukes Hamilton, MD, MHS, FACP, FIDSA Dr. Hamilton has more than 20 years of experience in program management and research on TB, HIV, and other infectious diseases. Dr. Hamilton is a Senior Scientist at Family Health International (FHI) and Professor of Medicine at Duke University in Durham, North Carolina. Dr. Hamiltonís major interest centers on tuberculosis (TB) and TB-HIV/AIDS, and she is involved in numerous clinical research activities that aim to improve treatment, diagnosis and prevention of both. She continues to work both domestically and internationally, serving as co-Chair of the Scientific Advisory Committee to IDSAís Center for Global Health Policy (Gates), the Executive Committee for the TB Trials Consortium (CDC), the Board of Coordinating Partners for TB CARE (USAID), and the Stop TB Partnership TB/HIV Core Working Group (WHO).

    See more of: Update on Tuberculosis
    See more of: Pre-meeting Session
    Previous Presentation | Next Presentation >>

    Findings in the abstracts are embargoed until 12:01 a.m. EST Thursday, Oct. 20 with the exception of research findings presented at IDSA press conferences.